Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Performance Nutrition

This article was originally published in The Tan Sheet

Executive Summary

Performance Nutrition: Appoints Anthony Ross CEO and president and David Wynne secretary, replacing Gary Lewellyn as chairman, CEO and president and Tamara Halling (Lewellyn's wife) as secretary and treasurer following publication of a news article detailing Lewellyn's involvement in a $16.7 mil. embezzlement case and a Securities and Exchange Commission lawsuit. The company's new management has begun an investigation into the "conduct of prior management and the accuracy of the company's financial statements for the fiscal year ended Sept. 30, 1995" and will call a special shareholders meeting at the earliest possible date. The firm also expands its board from five to 11 members...

Performance Nutrition: Appoints Anthony Ross CEO and president and David Wynne secretary, replacing Gary Lewellyn as chairman, CEO and president and Tamara Halling (Lewellyn's wife) as secretary and treasurer following publication of a news article detailing Lewellyn's involvement in a $16.7 mil. embezzlement case and a Securities and Exchange Commission lawsuit. The company's new management has begun an investigation into the "conduct of prior management and the accuracy of the company's financial statements for the fiscal year ended Sept. 30, 1995" and will call a special shareholders meeting at the earliest possible date. The firm also expands its board from five to 11 members....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085997

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel